General Announcement::Approval from Russian Ministry Healthcare to market Momate Rhino metered nasal spray as OTC product

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
25-Apr-2019 11:45:57
Status
New
Announcement Sub Title
Approval from Russian Ministry Healthcare to market Momate Rhino metered nasal spray as OTC product
Announcement Reference
SG190425OTHRL0J8
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
25/04/2019 09:15:00
Description (Please provide a detailed description of the event in the box below)
Glenmark receives approval from Russian Ministry of Healthcare to market Momate Rhino metered nasal spray as an Over-the-Counter (OTC) product

Attachments

PR_SGX_25042019.pdf
Total size =292K